Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conformational and dynamic considerations in peptide structure-function studies

V J Hruby, H I Mosberg

    Peptides
    |May 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of action in vitro and in vivo.

    Journal of thrombosis and haemostasis : JTH·2008
    Same author

    Design of high affinity cyclic pentapeptide ligands for kappa-opioid receptors.

    The journal of peptide research : official journal of the American Peptide Society·2005
    Same author

    Roles of residues 3 and 4 in cyclic tetrapeptide ligand recognition by the kappa-opioid receptor.

    The journal of peptide research : official journal of the American Peptide Society·2005
    Same author

    Quantification of helix-helix binding affinities in micelles and lipid bilayers.

    Protein science : a publication of the Protein Society·2004
    Same author

    Structure-based design, synthesis, and pharmacologic evaluation of peptide RGS4 inhibitors.

    The journal of peptide research : official journal of the American Peptide Society·2004
    Same author

    Development and validation of opioid ligand-receptor interaction models: the structural basis of mu vs delta selectivity.

    The journal of peptide research : official journal of the American Peptide Society·2002
    Same journal

    Potential role of intelectin-1 in the regulation of feeding of goldfish (Carassius auratus).

    Peptides·2026
    Same journal

    Cocaine- and amphetamine-regulated transcript (CART) peptides: Neuroanatomical distribution and functional implications in the mammalian central nervous system.

    Peptides·2026
    Same journal

    P1642-1, a novel pancreatic polypeptide analogue, ameliorates cognitive impairment in 5 ×FAD mice and is associated with enhanced PINK1/Parkin-related mitophagy.

    Peptides·2026
    Same journal

    Structure-based rational design of high-affinity JAZF1 variants peptides to target the testicular orphan nuclear receptor 4 and pro-opiomelanocortin axis in Cushing's disease.

    Peptides·2026
    Same journal

    [Gly<sup>2</sup>]-GLP-2(1-5): An ultra-short GLP-2 peptide for intestinal mucosal protection in inflammatory bowel disease.

    Peptides·2026
    Same journal

    The role of Kiss1 neurons in regulating metabolism and energy balance.

    Peptides·2026
    See all related articles

    Designing conformationally restricted peptide analogs improves understanding of peptide-receptor interactions. This approach enhances specificity, stability, and potency for drug development, exemplified by potent oxytocin antagonists.

    Area of Science:

    • Medicinal Chemistry
    • Molecular Pharmacology
    • Biophysics

    Background:

    • Small peptide hormones and neurotransmitters are conformationally flexible, hindering structure-activity relationship studies.
    • Understanding peptide-receptor interactions is crucial for drug design but limited by molecular lability.

    Purpose of the Study:

    • To explore conformation-activity relationships by designing conformationally restricted peptide analogs.
    • To develop potent peptide antagonists with improved specificity and stability.

    Main Methods:

    • Design and synthesis of semi-rigid peptide analogs.
    • Conformational analysis in various solvent environments.
    • Evaluation of biological activity at membrane receptors.

    Related Experiment Videos

    Main Results:

    • Conformationally restricted analogs exhibit enhanced receptor specificity and in vivo stability.
    • Specific conformational properties differentiate between agonist and antagonist analogs.
    • Potent oxytocin antagonists were designed using this approach.

    Conclusions:

    • Restricted peptide analogs provide a rational basis for understanding conformation-activity relationships.
    • This strategy is applicable to various peptide systems, including somatostatin and angiotensin.
    • Further development holds promise for orally active peptide therapeutics.